id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-0224-0019,FDA,FDA-2000-N-0224,OMB Review re: Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Proposed Rule,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:44:32Z,,0,0,09000064804d5424
FDA-2000-N-0224-0020,FDA,FDA-2000-N-0224,Tab A: Draft of FRN 67FR22367 Publication Date: 05/03/2002 to OMB,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:44:11Z,,0,0,09000064804d5427
FDA-2000-N-0224-0022,FDA,FDA-2000-N-0224,OMB Review re: Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Notice of Proposed Rule Making,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:43:11Z,,0,0,09000064804d542b
FDA-2000-N-0224-0021,FDA,FDA-2000-N-0224,Tab B: Draft of FRN 67FR22367 Publication Date: 05/03/2002 to OMB,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:43:48Z,,0,0,09000064804d5423
FDA-2000-N-0224-0024,FDA,FDA-2000-N-0224,Tab A: Draft of FRN 68FR69009 Publication Date: 12/11/2003 to OMB,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:42:42Z,,0,0,09000064804d5426
FDA-2000-N-0224-0025,FDA,FDA-2000-N-0224,Tab B: Draft of FRN 68FR69009 Publication Date: 12/11/2003 to OMB,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:42:18Z,,0,0,09000064804d5422
FDA-2000-N-0224-0023,FDA,FDA-2000-N-0224,OMB Review: Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Final Rule,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:16:13Z,,0,0,09000064804d5425
FDA-2000-N-0224-0004,FDA,FDA-2000-N-0224,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Notice of Approval,Notice,Notice of Approval,2003-12-16T05:00:00Z,2003,12,2003-12-16T05:00:00Z,,2015-12-09T14:52:39Z,,0,0,09000064804d542a
FDA-2000-N-0224-0003,FDA,FDA-2000-N-0224,Supporting Statement re: Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format - Agency Information Collection Activities,Supporting & Related Material,Background Material,2003-12-16T05:00:00Z,2003,12,,,2015-12-09T14:45:25Z,,0,0,09000064804d5429
FDA-2000-N-0224-0002,FDA,FDA-2000-N-0224,Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Final Rule,Notice,Notice of Final Rule,2003-12-12T05:00:00Z,2003,12,2003-12-09T05:00:00Z,,2015-11-17T15:33:29Z,,0,0,09000064804d5428
FDA-2000-N-0224-0001,FDA,FDA-2000-N-0224,Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Proposed Rule,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2002-05-03T04:00:00Z,2002,5,2002-05-01T04:00:00Z,2002-08-02T03:59:59Z,2015-11-18T02:30:47Z,,0,0,09000064804d540d